Cancer

A New Score Could Help Doctors Predict Which Liver Cancer Patients Will Benefit from a Three-Pronged Treatment A new clinical...

A hidden layer of genetic regulation in prostate cancer may offer researchers a new way to weaken aggressive tumors without...

A simple change in how surgeons identify lymph nodes could offer a new route to reducing the extent of axillary...

A Druggable Cellular Circuit Could Explain Port-Wine Stains—and Point to New Treatments A molecular pathway long associated with immune suppression...

A non-invasive combination of liver stiffness measurements and blood tests could substantially improve the early detection of sinusoidal obstruction syndrome,...

A Hidden Fourth Type of Lung Tumour May Explain Why Some “Low-Grade” Cancers Turn Aggressive A large international study has...

Colorectal cancer is increasingly appearing in people who are too young to have been considered part of the disease’s traditional...

Glioblastoma has long been regarded as one of the most formidable cancers to treat, not only because its cells infiltrate...

A Three-Drug Strategy Nearly Doubled Survival in Advanced Melanoma—but Researchers Urge Caution A real-world study of patients with unresectable advanced...

A large study of older women with screen-detected breast cancer suggests that 3D breast imaging does not deliver the same...

Lung Cancer Screening Misses Many People Who Go on to Develop the Disease A national analysis of adults diagnosed with...

A Simple Catheter-Care Bundle Nearly Eliminated Phlebitis in Children Receiving Cancer Treatment For children with cancer, a device designed to...

A 1,389-Patient Study Challenges Assumptions About Fluorescent Dyes in Glioblastoma Surgery For surgeons operating on glioblastoma, the boundary between malignant...

A Second Cancer Has Touched More Than 2.5 Million US Survivors, Study Finds More than 2.5 million people living in...

A new analysis of the phase 3 ORIENT-11 trial suggests that the future of lung-cancer immunotherapy may depend not only...

A new analysis of the Japanese JBCRG-M06/EMERALD trial is sharpening the debate over how best to deliver first-line therapy for...

A major collection of late-breaking research from the 2026 MASCC/ISOO Annual Meeting has been published in Supportive Care in Cancer,...

A new artificial intelligence model is opening a potential path toward more personalized treatment for patients whose lung cancer has...

Cancer is often described as an older person’s disease, but a qualitative study of young adults in the United States...

Cancer survivors who leave specialist oncology clinics for follow-up in primary care are not disappearing from the cancer system, according...